50+ years of scientific excellence
For more than 50 years, we’ve asked, “What if we tried this?” That curiosity, and the willingness to push boundaries, is part of how we work.
Where Breakthroughs Become Therapies
We bring clinical visions to life.
Scientifically. Globally. Seamlessly.
Driven by science. Delivered with purpose.
We provide specialty lab solutions to sponsors worldwide, customized to your program and grounded in science, to help accelerate your drug development.
Specialty lab solutions that scale with your study
Oncology breakthroughs, emerging disease research, complex therapeutics development – we have the range and scale to support your most important work.
Specialty lab testing
Cerba Research has an extensive history providing specialty lab and biomarker services. It’s in our DNA. Benefit from our customized service to obtain innovative, flexible solutions grounded in scientific expertise.
Centralized lab management
Leverage our global logistical and laboratory network, covering five continents. Cerba Research’s agile, customer-centric approach helps support the management of your clinical trials.
Therapeutic areas
We support programs across oncology, cell and gene therapy, infectious disease and vaccines, inflammation and immunology, metabolic diseases, neurology, and rare disease, with scientific expertise in each.
Why Cerba Research?
Integrated specialty and central lab workflow
Specialty expertise and central lab scale come together in one workflow, from the most complex assays to global trial coordination, to help your studies move faster.
Global reach, local execution
Our network spans 42 laboratories across five continents, and every sample still gets individual attention.
Harmonized lab platforms
We work to one global standard across our labs, from Stockholm to São Paulo, so you get consistent quality wherever your trial takes you.
Our track record
42
laboratories globally
1,400+
clinical trials since 2018
>300
studies ongoing
30
publications per year
Specialized services to solve complex challenges
Every breakthrough therapy starts with the right assay, the right expertise, and the right approach.
Biomarkers
Discover our experience in the field of circulatory biomarkers. As your global partner for integrated clinical trial laboratory and diagnostic solutions, our goal at Cerba Research is to generate early scientific insights that optimize your protocol.
Immunoassays
You can rely on Cerba Research to outsource your research questions, including efficacy, safety, passive immunization, immunogenicity, pharmacokinetics, pathogenicity, antiviral therapy, antiviral prophylaxis, drug delivery, resistance mutants, and more.
Genomics
Leverage Cerba Research’s three-decade-plus experience in genomic sequencing to support your research.
Flow cytometry
Connect with our scientific team to learn how FCM can enhance your research and help you develop the panels you need.
Driving innovation across therapeutic areas
Tailored lab solutions turn scientific potential into patient impact with precision and speed, from oncology breakthroughs to rare and infectious diseases.
Oncology
Immuno-oncology and personalized medicine have sparked a revolution in cancer research, but working with global patient populations brings complex challenges.
Cerba Research shapes and advances your complex trials by leveraging industry-leading labs, patient databases, and scientific experts spanning five continents.
Because when it comes to cancer, every breakthrough matters. We don’t compromise.
Anti–infectives and vaccines
We provide world-class operational expertise, logistical infrastructure, and the scientific rigor needed to effectively characterize, research, and treat infectious diseases as they emerge.
We deploy an expert global team with the experience, knowledge, and cutting-edge technologies to accelerate clinical trials, reducing time to treatment. Empowered by our people, science, and technology.
Cell and gene therapy
We facilitate state-of-the-art technology, subject matter expertise, and specialized logistics and operations to accelerate cell and gene therapy development. Additionally, we ensure global distribution of sample kits, providing easy access worldwide.
Our specialized pick-up and transport services maintain the integrity of samples by utilizing dry ice and ensuring global coverage.
We’re not just running your trials. Together, we’re writing the next chapter of human health.
Inflammation and immunology
We advance inflammation and immunology research with specialized assays, immune cell profiling, and biomarker-driven insights supported by expert scientific teams.
Our global sample handling capabilities, kit distribution, and tailored logistics preserve integrity and accelerate study timelines.
More than delivering data, we help you decode immune-driven disease and move transformative therapies closer to patients.
Committed to advancing science responsibly
Explore how our global laboratory network integrates ethical practices, environmental stewardship, and community impact into every aspect of our work. Discover the standards that guide us as we help shape a healthier, more sustainable future for patients – and for the planet.
Behind the scenes of the breakthroughs
Our scientists don’t just run assays. They solve puzzles.
Each whitepaper, case study, and research insight comes from real trials, real challenges, and real breakthroughs. This is where curiosity meets clinical impact. Explore the latest scientific publications, whitepapers, and case studies.
Welcome to Insight to Impact
Our global team shares insights across all areas of clinical trial development.
Blog
How to Validate Tumor Antigen Expression with Immunohistochemistry: Best Practices for Clinical Trials
Discover how to validate tumor antigen expression with IHC and avoid the HER2-low and PD-L1 pitfalls that skew patient selection and trial outcomes.
Blog
Tracking Clonal Evolution and Resistance with Next-Generation Sequencing
Up to 80% of relapses after targeted therapy are driven by pre-existing resistant subclones. Discover how deep NGS enables their detection and supports effective tracking of tumor evolution and resistance.
Blog
Flow Matters: Illuminating Immune Responses in Virology and Vaccine Testing
In this edition of the Flow Matters blog, we’re diving into how flow cytometry is transforming virology and vaccine research and how new technological advances are giving researchers an unprecedented view of the immune system in action.
Blog
Overcoming the Challenges of ADC Trials in Breast and Ovarian Cancer Treatment
Learn how ADC trials are advancing breast and ovarian cancer treatment while addressing resistance, biomarker, and trial design challenges.
